Lyell Immunopharma (LYEL) Insider Trading & Ownership $0.59 +0.04 (+6.42%) Closing price 03/27/2025 04:00 PM EasternExtended Trading$0.59 -0.01 (-1.28%) As of 03/27/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Lyell Immunopharma (NASDAQ:LYEL) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage25.10%Number OfInsiders Buying(Last 12 Months)4Amount OfInsider Buying(Last 12 Months)$429,550.00Number OfInsiders Selling(Last 12 Months)0 Get LYEL Insider Trade Alerts Want to know when executives and insiders are buying or selling Lyell Immunopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address LYEL Insider Buying and Selling by Quarter Remove Ads Lyell Immunopharma Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails3/21/2025Sumant RamachandraDirectorBuy200,000$0.58$116,000.00 3/17/2025Charles W NewtonCFOBuy200,000$0.56$112,000.00 3/14/2025Lynn SeelyCEOBuy175,000$0.61$106,750.00 3/14/2025Richard KlausnerDirectorBuy158,000$0.60$94,800.00 (Data available from 1/1/2013 forward) LYEL Insider Trading Activity - Frequently Asked Questions Who is on Lyell Immunopharma's Insider Roster? The list of insiders at Lyell Immunopharma includes Charles W Newton, Lynn Seely, Richard Klausner, and Sumant Ramachandra. Learn more on insiders at LYEL. What percentage of Lyell Immunopharma stock is owned by insiders? 25.10% of Lyell Immunopharma stock is owned by insiders. Learn more on LYEL's insider holdings. Which Lyell Immunopharma insiders have been buying company stock? The following insiders have purchased LYEL shares in the last 24 months: Charles W Newton ($112,000.00), Lynn Seely ($106,750.00), Richard Klausner ($94,800.00), and Sumant Ramachandra ($116,000.00). How much insider buying is happening at Lyell Immunopharma? Insiders have purchased a total of 733,000 LYEL shares in the last 24 months for a total of $429,550.00 bought. Lyell Immunopharma Key ExecutivesDr. Richard D. Klausner M.D. (Age 72)Founder & Executive Chairman Compensation: $80kDr. Lynn Seely M.D. (Age 65)Ph.D., President, CEO & Director Compensation: $962.23kMr. Charles W. Newton (Age 53)Chief Financial Officer Compensation: $744.74k1 recent tradesMr. Stephen J. Hill (Age 54)Chief Operating Officer Compensation: $775.97kDr. Gary Lee Ph.D. (Age 47)Chief Scientific Officer Compensation: $889.68kMr. Matthew Lang J.D. (Age 48)Chief Business Officer, Chief Legal Officer & Corporate Secretary Compensation: $596.25kProf. Stanley R. Riddell M.D.Founder & Scientific AdvisorDr. Crystal L. Mackall M.D. (Age 63)Founder & Scientific Advisor Nellie DilleryDirector of AccountingMs. Ellen RoseSenior Vice President of Communications & Investor Relations More Insider Trading Tools from MarketBeat Related Companies CRMD Insider Selling IMNM Insider Selling BCYC Insider Selling DNTH Insider Selling KURA Insider Selling CDXC Insider Selling KALV Insider Selling MGTX Insider Selling ARVN Insider Selling ANAB Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles NVIDIA Insiders Sell: This Is What It Means for the Market Top 3 Insider Stock Buys in March—Are They Still Good in April?Grocery Outlet Insider and Institutional Buyers Signal BottomSentinelOne Insider Selling? Why Investors Should Stay Bullish 3 Companies Buying Back Stock—Why It Matters This page (NASDAQ:LYEL) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredA $6.9 Trillion Cash Tsunami Is Coming – Move Your Money NOWExpert: "Prepare For the Mother of All Melt-Ups" In the wake of Wall Street volatility, stock-picking legen...Stansberry Research | SponsoredTrump’s Bitcoin Reserve is No Accident…Bryce Paul believes this is the #1 coin to buy right now The catalyst behind this surge is a massive new b...Crypto 101 Media | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lyell Immunopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lyell Immunopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
